Global CD137 Antibodies Clinical Trials Research Report 2023: Insights on More Than 60 CD137 Antibodies in Clinical Trials - ResearchAndMarkets.com
The "Global CD137 Antibodies Clinical Trials & Market Trends Insight 2023" report has been added to ResearchAndMarkets.com's offering.
- The "Global CD137 Antibodies Clinical Trials & Market Trends Insight 2023" report has been added to ResearchAndMarkets.com's offering.
- The therapeutic potential of CD137 has been investigated exhaustively and has now been confirmed as studies from running clinical and research studies emerge.
- Utomilumab and Urelumab were among the first CD137 agonists to be developed and introduced in human clinical trials.
- Global CD137 Antibodies Clinical Trials Insight by Company, Indication & Phase
CD137 Therapeutic Approaches by Monoclonal, Bispecific, Trispecific & Tetraspecific Antibodies